Role of Bile Acid Pathway Intermediates in Pathology of CTX
Creators
Contributors
Project leaders:
Project members:
Description
A deficiency in the enzyme sterol 27-hydroxylase (CYP27A1) leads to the autosomal recessive disorder cerebrotendinous xanthomatosis (CTX). CYP27A1 catalyses the first steps of the acidic pathway of bile acid biosynthesis. Most cells express CYP27A1, and a deficiency in this enzyme results in the activation of shunt pathways to help remove excess cholesterol. CYP27A1 also appears in the middle of the neutral pathway of bile acid biosynthesis and its deficiency results in accumulation of up-stream pathway intermediates. Here we describe methods for the simultaneous analysis of almost all metabolites from cholesterol to bile acids in a single assay and discuss the relative importance of accumulation of pathway intermediates and missing metabolites to the pathology of CTX.
Files
231029_Griffiths_CTX_with_Figures.pdf
Files
(653.2 kB)
Name | Size | Download all |
---|---|---|
md5:e36ab0051e70ac3cb22e82b814eb003b
|
653.2 kB | Preview Download |
Additional details
Funding
- Medical Research Council
- Lipidomics and metabolomics for rare disease diagnosis MR/Y008057/1
- Medical Research Council
- Spatial Cholesterol Metabolism: A Mass Spectrometer for Better Diagnosis and Understanding of Disease MR/X012387/1
- Biotechnology and Biological Sciences Research Council
- An Integrated platform for Quantitative Sterolomics: From Oxysterols to Bile Acids and Steroids BB/I001735/1
- Biotechnology and Biological Sciences Research Council
- Mass Spectrometry Based Lipidomics and Metabolomics to Drive Bioscience Discovery BB/S019588/1
- Biotechnology and Biological Sciences Research Council
- Identification of endogenous ligands for the Retinoid-related Orphan Receptor gamma BB/L001942/1
Dates
- Created
-
2023-10-29